Industry experts, policymakers, and regulators gathered today at the Andhra Pradesh MedTech Zone (AMTZ) for a national conference focused on “Enhancing Pharmaceutical Quality Assurance through Good Manufacturing Practices (GMP).” Organized by the PHD Chamber of Commerce and Industry (PHDCCI), in collaboration with the Ministry of Chemicals and Fertilizers and AMTZ, the event highlighted GMP’s vital role in ensuring the production of safe, effective, and high-quality pharmaceutical products.
The conference emphasized that GMP goes beyond regulatory compliance, providing a comprehensive framework to guarantee product quality, safety, and effectiveness. Key discussions centered on how standardization, accurate documentation, and rigorous quality control practices can minimize risks such as contamination and defects. Industry leaders also underscored the importance of integrating GMP with emerging technologies to streamline processes and meet international standards.
In the competitive business landscape, attracting investment is essential for pharmaceutical companies seeking growth, enhanced products, and expanded market presence. Adopting GMP is a key factor in securing investment, as it signals commitment to high-quality standards and operational excellence.
Dr Nasir Jamal, Director of PHDCCI, commented, “GMP is fundamental in ensuring the production of high-quality, safe, and effective pharmaceutical products. With initiatives like GMP and the restructured RPTUAS, India’s pharmaceutical sector is poised to achieve global competitiveness while prioritizing public health.”
Dr Jitendra Sharma, Managing Director and CEO of AMTZ, shared insights on the organization’s evolution, stating, “AMTZ has always focused on bridging science and business for the benefit of society. By offering GMP certifications and validation ecosystems, we aim to help industries align certification, regulation, and production in a seamless manner. Our growth from concept to reality showcases the power of collaboration in reshaping healthcare manufacturing in India.” Dharmendra Kumar Yadav highlighted the future of the industry, saying, “The future holds immense potential, but it requires continuous innovation and an unwavering commitment to quality.”
The event featured sessions by prominent speakers, including Dr Nasir Jamal, Dr Jitendra Sharma, Poosarla Rajesh, Dr. Kilari Eswar Kumar, and K. Bhuvaneswari. The conference also included a detailed presentation on the RPTUAS by Yashwant Shinde of SIDBI, offering valuable insights into the scheme’s benefits for technological upgrades in the pharmaceutical sector.
This conference symbolizes a concerted effort to strengthen India’s pharmaceutical manufacturing industry through quality assurance and innovation. GMP ensures patient safety, while the RPTUAS scheme provides the necessary support for industries to modernize and scale up, enabling them to compete on a global level.
